Media Release

All Categories

29 November 2023

US FDA Grants the BiVACOR Total Artificial Heart IDE Approval for First-in-Human Early Feasibility Study

Media Release

Bivacor team

19 October 2021

Blade Therapeutics Initiates Additional Phase 1 Clinical Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis

Media Release

14 October 2021

Blade Therapeutics Announces FDA Orphan Drug Designation Granted to Cudetaxestat for Treatment of Systemic Sclerosis

Media Release

07 October 2021

Blade Therapeutics Announces Publication of Preclinical Evidence Supporting Neuroprotective Effects of Proprietary Calpain Inhibitor in a Rare Inherited Neurodegenerative Disease

Media Release

31 August 2021

OneVentures takes VC industry lead on ESG investment and oversight

Announcement, Media Release

02 June 2021

Preclinical studies from Vaxxas and Collaborators Reveal Potential of Vaxxas’ Novel High-Density Microarray Patch (HD-MAP) to Effectively Deliver SARS-CoV-2 Spike Vaccine

News, Media Release

12 January 2021

Clinical Genomics Announces Nationwide Expansion of Patient Access to COLVERA®

News, Media Release

30 November 2020

OneVentures Growth (Equity) Fund V combines capital and executional support to tech companies

News, Media Release

15 November 2020

Clinical Genomics Announces Medicare Coverage Applicable to COLVERA® (Liquid Biopsy Test to Detect Recurrence of Colorectal Cancer)

Media Release

06 October 2020

Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response

Media Release

12 August 2020

Blade Therapeutics Updates Enrollment Progress for Phase 2 Study of Lead Investigational Therapy BLD-2660 in Treating Patients with COVID-19 Pneumonia

Media Release

10 August 2020

Blade Therapeutics Appoints Accomplished Biopharmaceutical Executive, Mark Timney, as Chairman of the Board

Media Release

03 August 2020

KiRA Biotech appoints Global Pharma Business Leader as Independent Board Chair

Media Release

02 August 2020

FDA Approves Xeglyze™ for the topical treatment of head lice infestation

Media Release

22 July 2020

OneVentures Venture Credit Fund poised to invest $120M into Australian scaleups

Media Release

29 May 2020

Vaxxas announces that MSD exercises option to apply novel immune system activation platform for vaccine candidate

Media Release

28 May 2020

Harro Höfliger and Vaxxas announce alliance to develop industrial‐scale aseptic processing line for vaccine products based on Vaxxas’ High Density Microarray Patch (HD‐MAP)

Media Release

27 May 2020

Clinical Genomics announces publication of Additional positive data reinforcing key benefits of COLVERA®

Media Release

19 May 2020

OneVentures expands team to internationalise its healthcare portfolio

Media Release

30 April 2020

Clinical Genomics expands strategic relationship with Quest Diagnostics and further increases momentum for innovative first-line colorectal cancer screening blood test

Media Release

17 March 2020

Vaxxas Publication in PLoS Medicine Reveals Groundbreaking Clinical Research on Broad Potential of Novel High-Density Microarray Patch (HD-MAP)

Media Release

16 March 2020

OneVentures invests in international software company Phocas, bringing business back to Australia and positioning the company for international expansion

Media Release

15 January 2020

Pearson acquires interactive learning technology from Smart Sparrow

Media Release

06 November 2019

iStaySafe Acquires Find-Me Technologies, Strengthens position in the IoT Industry

Media Release

decor decor decor
decor decor decor decor decor